Is Acetaminophen or Ibuprofen Better for Back Pain?

Ibuprofen is the stronger choice for most back pain. Multiple trials and meta-analyses have found that acetaminophen performs no better than a placebo for acute low back pain, while ibuprofen, as a nonsteroidal anti-inflammatory drug, consistently reduces pain and is endorsed by major clinical guidelines as a first-line medication when drugs are needed. The gap between the two is wider than most people realize, and the reasons involve how back pain actually works at the tissue level.

Acetaminophen Struggles With Acute Back Pain

The most striking finding in back pain research over the past decade is how poorly acetaminophen performs on its own. The PACE trial, a large double-blind study across 235 primary care centers with 550 patients, found that acetaminophen taken either on a regular schedule or as needed was not more effective than a placebo for acute low back pain. That applied to pain intensity, physical functioning, quality of life, and time to recovery.¹ This was not a fluke result. A meta-analysis covering studies through 2015 concluded there was no substantial evidence that acetaminophen at the standard maximum dose was superior to placebo for short-term acute back pain, whether measured over one week or up to twelve weeks. A broader 2021 meta-analysis of 36 previous systematic reviews reached the same conclusion: acetaminophen alone provides no meaningful benefit for acute low back pain.²

Ibuprofen, by contrast, does outperform placebo. When emergency departments have compared intravenous acetaminophen, ibuprofen, and another NSAID (dexketoprofen) head-to-head for acute low back pain, all three reduced pain substantially from baseline, and there was no significant difference between them. The average pain reduction on a visual scale was about 40 to 43 millimeters out of 100, regardless of which drug was used.³ That might sound like acetaminophen held its own, but the crucial context is route of delivery: intravenous administration bypasses some of the absorption issues that limit oral acetaminophen. In the larger body of oral studies, acetaminophen simply does not produce reliable pain relief for this condition.

Why the Difference Exists

Back pain, especially the common non-specific kind, usually involves inflammation in the muscles, joints, or tissues surrounding the spine. Ibuprofen works by blocking the enzymes that produce prostaglandins, the chemical messengers that drive inflammation and amplify pain signals. It tackles both the pain and the underlying inflammatory process fueling it. Research in animal models of spinal inflammation has demonstrated that ibuprofen suppresses the hyperexcitability of sensory neurons and reduces inflammatory markers in the affected nerve tissue.⁴

Acetaminophen’s mechanism is less clear-cut. Despite decades of widespread use, researchers still have not pinpointed exactly how it relieves pain. It appears to work primarily in the central nervous system rather than at the site of injury, and it has little to no anti-inflammatory activity.⁵ For conditions where inflammation is a major driver of pain, that difference matters enormously. Acetaminophen can take the edge off a headache or reduce a fever, but it is poorly equipped to address the kind of tissue-level inflammation that makes your lower back seize up.

What About Chronic Back Pain

The evidence picture shifts somewhat when back pain becomes chronic, lasting three months or longer. A comprehensive review of over-the-counter treatments for chronic low back pain found that both NSAIDs and acetaminophen are considered effective in this setting, alongside other drug classes like muscle relaxants and certain antidepressants.⁶ That said, a systematic comparison of the two drugs specifically for back pain noted the data were limited, making it hard to draw confident conclusions about which performs better in the chronic setting.⁷

The American College of Physicians guideline for chronic low back pain recommends trying non-drug approaches first, things like exercise, yoga, cognitive behavioral therapy, or spinal manipulation. If those are not enough, NSAIDs are the first-line medication, with tramadol or duloxetine as second-line options. Acetaminophen is not singled out as a recommended drug for chronic back pain in this guideline.⁸ The pattern is consistent: when guidelines distinguish between the two, ibuprofen and other NSAIDs get the nod over acetaminophen for back pain specifically.

Does Adding Acetaminophen to Ibuprofen Help

Plenty of people figure that if one pill helps, two different pills should help more. For other types of pain, like dental pain after a procedure, combining acetaminophen and ibuprofen does seem to produce better relief than either alone. Back pain does not follow that pattern. A randomized, double-blind trial in two emergency departments assigned 120 patients with acute, non-radicular low back pain to either ibuprofen plus a placebo or ibuprofen plus acetaminophen. At one week, about 28% of patients in both groups still reported moderate or severe pain, and the functional improvement scores were nearly identical.⁹

A more recent systematic review and meta-analysis of paracetamol combination therapy did find a small, statistically significant pain reduction when oral acetaminophen was added to an NSAID for low back pain at the immediate term. The difference was modest, roughly a 6-point improvement on a 100-point scale compared to ibuprofen alone.¹⁰ Whether a 6-point shift on a 100-point scale translates to a noticeable difference for the patient is debatable. Most researchers consider 10 to 20 points on such a scale to be the threshold where someone actually feels meaningfully better. So while the combination is not useless, you should not expect a dramatic upgrade by stacking the two drugs.

Safety Tradeoffs to Consider

One reason acetaminophen remains so widely recommended for general pain is its reputation as the gentler option, particularly on the stomach. That reputation is earned but more nuanced than most people think. In one study comparing GI side effects at over-the-counter doses for up to seven days, ibuprofen and acetaminophen actually had similar rates of stomach-related complaints, and both were significantly better tolerated than aspirin.¹¹ Another study found GI side-effect rates of about 7% for ibuprofen and about 8% for acetaminophen at OTC doses, with serious GI toxicity being rare for both.¹² At short-term, standard doses, the stomach-safety gap between the two is smaller than most people assume.

That gap widens with longer use or higher doses. Ibuprofen and other NSAIDs carry well-documented risks when used chronically, including kidney problems. A retrospective study of over 180,000 patients with osteoarthritis or chronic low back pain found that the rate of kidney events was about 23 per 10,000 person-years among NSAID users, and the risk climbed with longer treatment duration. Patients who used NSAIDs for one to three years had about a 32% higher risk of kidney events compared to those who used them for less than a year. Elderly patients and those with diabetes, high blood pressure, or cardiovascular disease faced the highest risk.¹³

Ibuprofen’s cardiovascular risk is lower than some other NSAIDs but is not zero, and it also depends on dose, duration, and the patient’s underlying health.¹⁴ A large propensity-matched study of over 35,000 patient pairs found similar rates of cardiac complications and death between those prescribed NSAIDs and those who were not, suggesting the short-term cardiovascular risk for the general population is quite low.¹⁵

Acetaminophen’s signature risk is liver damage. A prospective study of 400 patients with acetaminophen-related acute liver injury found that about one in five had taken only therapeutic doses, defined as less than 6 grams per day.¹⁶ The standard recommended maximum is 4 grams per day, but accidental overdose is surprisingly easy because acetaminophen lurks in dozens of combination products, from cold medicines to prescription painkillers. Patterns of medication use that lead to exceeding the recommended daily maximum have been documented as a real-world concern.¹⁷ If you are using acetaminophen for back pain, you need to check every other medication you take to make sure you are not doubling up.

What Official Guidelines Recommend

The American College of Physicians guideline, one of the most widely cited in the field, lays out a clear order of operations. For acute or subacute low back pain, non-drug treatments come first: heat, massage, acupuncture, or spinal manipulation. If you want medication, the recommendation is NSAIDs or muscle relaxants, supported by moderate-quality evidence. Acetaminophen is not listed as a recommended option for acute back pain.⁸ This was a significant shift from older guidelines that had long included acetaminophen as a default first choice. The PACE trial and subsequent meta-analyses essentially pulled the rug out from under that recommendation.

International guidelines from the World Federation of Neurosurgical Societies echo this stance, specifically noting that multiple studies argue against a significant benefit of acetaminophen for acute low back pain and that heat wrap therapy actually outperformed both acetaminophen and ibuprofen in one trial.² That last finding is worth sitting with: a heat wrap worn for eight hours outperformed 4,000 mg of acetaminophen per day and also beat 1,200 mg of ibuprofen per day, improving flexibility, stiffness, and disability more than either drug.

How Quickly Each Drug Works

If you are reaching for a pill because your back just locked up, you might wonder which one kicks in faster. The pharmacokinetic differences are real but small. Acetaminophen is absorbed slightly faster than ibuprofen: its absorption half-life is about 12 minutes compared to about 27 minutes for ibuprofen, and it starts getting into the bloodstream a minute or two sooner. However, when researchers modeled how quickly each drug actually reduces a pain score by a meaningful amount (2 points on a 10-point scale), the difference was only 5 to 10 minutes across various formulations.¹⁸ Eating before you take either drug slows absorption more than switching between the two does. If speed is your primary concern, taking the pill on a light stomach matters more than which pill you choose, though ibuprofen should still generally be taken with some food to minimize stomach irritation.

Topical NSAIDs for Back Pain

Topical pain creams and gels have become increasingly popular, and they appeal to people who want to avoid the systemic side effects of pills. For joint and muscle injuries in general, topical NSAIDs perform about as well as oral NSAIDs, with fewer GI side effects but more local skin reactions like redness or itching.¹⁹ Back pain, however, seems to be a harder target for topical delivery. A 2024 randomized trial comparing topical diclofenac gel to oral ibuprofen for acute low back pain found that oral ibuprofen produced greater improvement two days after the emergency department visit. Patients on oral ibuprofen improved by about 10 points on a functional scale, while those using topical diclofenac alone improved by about 6 points. Adding the topical gel to the oral pill did not produce additional benefit.²⁰

The likely explanation is anatomical. Topical drugs work best when the target tissue is close to the skin surface, like a swollen knee or an inflamed tendon. The muscles, discs, and joints of the lumbar spine sit under layers of tissue that a topical gel has trouble penetrating in therapeutic concentrations. For back pain specifically, swallowing the ibuprofen remains the more effective route.

The Placebo Factor in Back Pain

One of the more humbling findings in back pain research is the size of the placebo response. A systematic review and meta-analysis of placebo effects in low back pain found that the modest effect sizes seen across many back pain treatments could be “predominantly caused by placebo effects.”²¹ In a controlled trial measuring the placebo response directly, patients with chronic low back pain experienced an initial pain reduction of about 54% after receiving a placebo, which tapered to about 29% after seven hours.²²

This context matters for the acetaminophen-versus-ibuprofen question because it helps explain why many people swear acetaminophen works for their back: they take it, their pain eventually eases, and they credit the drug. But the PACE trial showed that the same improvement happens with a sugar pill. Most episodes of acute low back pain improve on their own within a few weeks regardless of what you take. The drug that actually outperforms placebo for this condition is ibuprofen, not acetaminophen. Still, if you have a reason to avoid ibuprofen and acetaminophen provides you with subjective comfort, the placebo component might be doing some real work for you, since placebo effects in pain are mediated by genuine neurological pathways, not imagination.

When Acetaminophen Might Still Be the Right Call

Despite ibuprofen’s clear advantage for back pain in the research, there are specific situations where acetaminophen becomes the more practical choice. If you have a history of stomach ulcers or GI bleeding, even short-term NSAID use carries a risk you might not want to take. Endoscopy studies have shown that acetaminophen causes virtually no gastric mucosal injury, while ibuprofen causes measurable damage to the stomach lining, even over brief periods.²³ If you are on blood thinners, have kidney disease, are in the later stages of pregnancy, or already take another NSAID for a different condition, ibuprofen may be off-limits. In those cases, acetaminophen is not ideal for back pain, but it is safer for you than a drug that could worsen a more dangerous problem.

People who are already managing high blood pressure, heart failure, or kidney issues should be especially cautious with NSAIDs. The risk of kidney events in NSAID users climbs in these populations.¹³ For these individuals, acetaminophen or non-drug approaches like heat, gentle movement, and physical therapy become the default, not because they are superior for pain relief, but because the risk-benefit equation tilts against ibuprofen.